QIAstat-Dx COVID-19 research

• Detection of 22 respiratory targets including 2019-nCoV (SARS-CoV-2)
• Targets SARS-CoV-2 Orf1ab and E genes (similar to WHO-Charité test)
• Utilizes real-time PCR to deliver results with Ct values and amplification curves
• Cartridge accepts both dry swabs and transport medium liquid samples
• Research use only

To support the research efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN developed the QIAstat-Dx Respiratory 2019-nCoV Panel. This version of our multiplex syndromic cartridge detects and differentiates 22 respiratory targets, including 2019-nCoV (SARS-CoV-2) from Nasopharyngeal swabs (NPS).

The QIAstat-Dx Analyzer, combined with QIAstat-Dx assay cartridges, uses real-time PCR to detect pathogen nucleic acids in human biological samples. The QIAstat-Dx Analyzer and cartridges are designed as a closed system that enables hands-off sample preparation followed by detection and identification of pathogen nucleic acids. Samples are inserted into a QIAstat-Dx cartridge, which contains all the reagents to isolate and amplify nucleic acids from the sample. Detected real-time amplification signals are interpreted by the integrated software and are reported via an intuitive user interface.